Omeprazole
Gastric MALT Lymphoma
National Health Research Institutes, TaiwanSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the Gastric MALT Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Esomeprazole National Taiwan University Hospital | Phase 2 | CCC |
Orelabrutinib Fudan University | Phase 2 | CCC |
BISMUTH SUBCITRATE National Taiwan University Hospital | Phase 2 | CCC |
METRONIDAZOLE National Taiwan University Hospital | Phase 2 | CCC |
Tetracycline National Taiwan University Hospital | Phase 2 | CCC |
View all 10 →
Same molecule, other indications
Omeprazole is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →